Independent Wealth Network’s Akebia Therapeutics AKBA Stock Holding History

Independent Wealth Network’s Portfolio AKBA Stock Details AKBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.1K	Hold	13,003	–	–	0.01%	299
2025 Q4	$20.9K	Hold	13,003	–	–	0.01%	287
2025 Q3	$35.5K	Hold	13,003	–	–	0.01%	281
2025 Q2	$47.3K	Hold	13,003	–	–	0.02%	256
2025 Q1	$25K	Hold	13,003	–	–	0.01%	244
2024 Q4	$24.7K	Buy	13,003 +2,000	+18%	+$3.47K	0.01%	235
2024 Q3	$14.5K	Sell	11,003 -1,000	-8%	-$1.33K	0.01%	221
2024 Q2	$12.2K	Hold	12,003	–	–	0.01%	213
2024 Q1	$22K	Buy	+12,003	New	+$19.2K	0.01%	221

Other funds holding AKBA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Independent Wealth Network's AKBA Position: Q1 2026 in Review

Independent Wealth Network held its Akebia Therapeutics (AKBA) position steady in Q1 2026 at 13,003 shares worth $18.1K. The position accounts for 0.01% of the portfolio, ranked #299.

Independent Wealth Network first reported a position in AKBA in Q1 2024 and has held it in 9 quarters since. The position peaked at $47.3K in Q2 2025. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

Independent Wealth Network held 13,003 shares of Akebia Therapeutics worth $18.1K as of Q1 2026.
Independent Wealth Network left its Akebia Therapeutics share count unchanged in Q1 2026.
Akebia Therapeutics made up 0.01% of Independent Wealth Network's portfolio in Q1 2026, its #299 holding.
Independent Wealth Network first reported a position in Akebia Therapeutics in Q1 2024 and has held it in 9 quarters since.
Independent Wealth Network's Akebia Therapeutics position peaked at $47.3K in Q2 2025.
171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on Independent Wealth Network's 13F filing for Q1 2026, filed 21 Apr 2026.